Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003489432 | SCV004238679 | likely pathogenic | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003489432 | SCV004424119 | pathogenic | not provided | 2023-07-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe451Leufs*25) in the SLC4A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC4A1 are known to be pathogenic (PMID: 8943874, 10926824, 23255290). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SLC4A1-related conditions. For these reasons, this variant has been classified as Pathogenic. |